131 results
Page 3 of 7
8-K
nxpdny0m
24 May 21
Introduction to HT - KIT an mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell - Derived Cancers
8:00am
DEFR14A
08nxvf5q7w8t
7 May 21
Revised proxy
5:20pm
PRE 14A
qagg0k
26 Apr 21
Preliminary proxy
5:24pm
424B3
c2ecv9wa37n4gur gx7q
6 Apr 21
Prospectus supplement
6:07am
D
4c2bxb
16 Mar 21
$15M in equity / options / securities to be acquired, sold $15M, 13 investors
4:18pm
8-K
EX-10.4
0c9f pnl7
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.1
rci93ojzxgiyl37i34sk
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
cijhuwd
25 Jan 21
Other Events
8:00am
424B3
q65wpwcif8s0gfgz
19 Jan 21
Prospectus supplement
4:23pm
D
fs2wiim
8 Jan 21
$5M in equity / options / securities to be acquired, sold $5M, 3 investors
4:30pm
8-K
EX-10.1
5df4 zpx32
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.3
1dwma7b4
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
ujcby9 xp6
21 Sep 20
Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-go COVID-19 Testing Device
4:15pm